ClearOne announces 1-for-15 reverse stock split
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CLRO:
Disclaimer & DisclosureReport an Issue
Clearone Communications Approves Reverse Stock Split
Upcoming Stock Splits This Week (June 2 to June 6) – Stay Invested
ClearOne Announces Reverse Stock Split Plan
ClearOne announces 1-for-15 reverse stock split
ClearOne reports Q1 EPS (11c) vs. (7c) last year
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
11 minutes ago
- Business Wire
Regis to Issue Fourth Quarter and Full Year 2025 Results on September 3, 2025
MINNEAPOLIS--(BUSINESS WIRE)--Regis Corporation (NasdaqGM:RGS), a leader in the haircare industry, will issue financial results for the fourth fiscal quarter and full year ended June 30, 2025, before the market opens on September 3, 2025. Following the release, the Company will host a presentation via webcast for investors beginning at 7:30 a.m. Central time to discuss its corporate developments and financial performance. To participate in the live webcast, interested parties may register here or register by logging into A replay of the presentation will be available later that day at the same address. Investors with questions they would like addressed during the earnings call may submit them in advance to investorrelations@ About Regis Corporation Regis Corporation (NasdaqGM:RGS) is a leader in the haircare industry. As of March 31, 2025, the Company franchised or owned 4,087 salon locations. Regis' franchised and corporate locations operate under concepts such as Supercuts ®, SmartStyle ®, Cost Cutters ®, Roosters ® and First Choice Haircutters ®. For additional information about the Company, including a reconciliation of certain non-GAAP financial information and certain supplemental financial information, please visit the Investor Relations section of the corporate website at
Yahoo
2 hours ago
- Yahoo
How to Play Nvidia Stock as the Plot Over Its China Business Thickens
It's hard to keep Nvidia (NVDA), the world's biggest company and the first one to command a $4 trillion market cap, out of the news cycle. Over the last few weeks, Nvidia has been in the news regarding its China business, and most recently, Reuters reported that the company is developing a new chip for China. In this article, we'll look at some of the recent developments related to Nvidia's China business and examine the company's outlook. More News from Barchart Should You Buy the Pullback in Palantir Stock Today? The Quantum Computing Race Is On: These 2 Stocks Appear Poised to Lead As SoFi Launches International Money Transfer Services, How Should You Play SOFI Stock? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! Successive U.S. Governments Have Clamped Down on NVDA's Exports to China Why Nvidia's chips have been the building blocks for artificial intelligence (AI) models, they have also added a new dimension to the U.S.-China rivalry. President Joe Biden's administration imposed restrictions on Nvidia's export of advanced AI chips to China, citing fears over their dual military use. President Donald Trump's administration went a step further and blocked the exports of Nvidia's H20 chips to China. Nvidia had specifically designed these chips for China to meet the guidelines set by the U.S. government, and after the ban, it booked a charge of $4.5 billion in the first quarter of its fiscal 2026. Why Is China an Important Market for Nvidia? China was once Nvidia's second-largest market, but U.S. export control restrictions have taken a toll on its business there. During the fiscal Q1 2026 earnings call in May, CFO Collete Kress said, 'Losing access to the China AI accelerator market, which we believe will grow to nearly $50 billion, would have a material adverse impact on our business going forward and benefit our foreign competitors in China and worldwide.' Nvidia CEO Jensen Huang has said multiple times that the export restrictions would only fuel chip innovation in China as rivals, particularly Huawei, catch up. While the Trump administration has allowed Nvidia to resume H20 exports to China, the company will need to share 15% of its China revenues with the U.S. government. The unusual agreement left markets perplexed, as the ostensible reason the U.S. banned exports of advanced AI chips to China was because of national security concerns, and a cut in revenues does not help address that. Many see legal challenges to the revenue share agreement, and separately, lawmakers across the political divide have been critical of the export resumption. Reports suggest that Nvidia is developing a new AI chip for China. Tentatively named B30A, it is said to be based on the company's Blackwell architecture and would be more powerful than the H20, which is currently its most advanced chip sold in China. In its response to the reports of the new chip for China, Nvidia said, 'We evaluate a variety of products for our roadmap, so that we can be prepared to compete to the extent that governments allow.' It emphasized, 'Everything we offer is with the full approval of the applicable authorities and designed solely for beneficial commercial use.' China Does Not Looks Too Welcoming of Nvidia's H20 Meanwhile, the Chinese government hasn't been too welcoming of the H20 chip these days and has cautioned domestic companies against using these over fears of a U.S. government 'backdoor.' Nvidia has denied any such claims, but it remains to be seen whether Chinese companies defy the government warning to buy the H20. NVDA Stock Forecast Wall Street analysts are meanwhile not too perturbed by these concerns and have started raising Nvidia's target price ahead of its upcoming earnings report. TD Cowen raised Nvidia's target price to $235 and sees a 'clean narrative' for the stock despite concerns over its China business. Cantor Fitzgerald raised its target price from $200 to $240 as analyst C.J. Muse sees 'seemingly insatiable' demand for AI compute. Mizuho raised its target price from $192 to $205, while Morgan Stanley raised its from $200 to $206. All three brokerages expect Nvidia to beat consensus estimates when it reports its fiscal Q2 2026 earnings next week. Should You Buy NVDA Stock? While Nvidia's China business is shrouded in uncertainty, the company's non-China business is doing incredibly well. The June quarter earnings calls of other Big Tech companies, which include the so-called hyperscalers, showed that companies are not slowing down their AI capex, and if anything, they are doubling down amid early signs of monetization. Sovereign AI is yet another growth driver for Nvidia, as, given the growing importance of AI, major countries want to have more control over the technology. Huang has been globe-trotting for a reason and has been pitching sovereign AI on his trips to the Middle East and the European Union this year. Nvidia trades at a forward price-earnings (P/E) multiple of 45.2x, which does not look bloated in the context of the strong earnings growth that the company brings to the table. Moreover, markets never fully priced in a normal business environment for Nvidia in China, and any sales in the country would be incremental to Nvidia's top line and bottom line despite the 15% revenue share with the U.S. government. Overall, while the noise over the China business might put pressure on Nvidia stock in the near term, I continue to stay invested in the company and will use any further weakness to add to my positions. On the date of publication, Mohit Oberoi had a position in: NVDA. All information and data in this article is solely for informational purposes. This article was originally published on Error al recuperar los datos Inicia sesión para acceder a tu cartera de valores Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos
Business Wire
2 hours ago
- Business Wire
Modivcare Enters into Comprehensive Restructuring Agreement to Strengthen its Future, Reduce Debt and Inject Capital
DENVER--(BUSINESS WIRE)--Modivcare Inc. (the 'Company' or 'Modivcare') (Nasdaq: MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced that it has taken necessary and decisive action intended to strengthen its financial foundation while continuing to provide access to care, reduce costs, and improve outcomes for clients and members nationwide. Modivcare has filed for voluntary Chapter 11 protection in the U.S. Bankruptcy Court for the Southern District of Texas to implement a comprehensive restructuring transaction with the support of a supermajority of its key stakeholders. Through this process, Modivcare intends to build a stronger, sustainable organization, positioned for growth and well-equipped to meet the critical needs of members across its non-emergency medical transportation, personal care services and remote patient monitoring service lines. 'Modivcare sits at the center of the preventive healthcare ecosystem,' said Heath Sampson, Chief Executive Officer and President of Modivcare. 'This recapitalization strengthens our balance sheet and allows Modivcare to accelerate our investment in innovation by combining technology and data with high-touch member engagement. As the connector to care, our seamlessly connected platform improves access, quality and cost for payors, providers and facilities, while positioning us to lead the future of coordinated care.' More than 90% of First Lien Lenders and more than 70% of Second Lien Lenders have entered into a Restructuring Support Agreement ('RSA') with the Company. Those lenders have committed to support the Company throughout this process and have agreed to provide $100 million in 'debtor-in-possession' ('DIP') financing to finance the restructuring process and to support ongoing operations during this expedited bankruptcy process. Upon the closing of the DIP loan, Modivcare will have liquidity in excess of $100 million. The restructuring will reduce the Company's total outstanding funded debt obligations by approximately $1.1 billion (which is more than 85% of its outstanding funded debt obligations) and will meaningfully reduce the Company's annual cash interest and transition ownership to a group of seasoned and well-funded investors who are committed to Modivcare's success. All of Modivcare's service lines will continue to operate in the ordinary course, and we expect no interruption or change in access to care and a continued focus on operational excellence. Modivcare intends to close this transaction quickly by exiting the restructuring process early in the fourth quarter of 2025. Modivcare remains committed to providing excellent service to clients and their members. The Company has filed customary motions that, once approved, will allow Modivcare to meet obligations to clients and critical vendors, including transportation providers, and pay employee wages and benefits as usual. For more information about the Company's Chapter 11 case, including claims information, please visit or contact Verita, the Company's noticing and claims agent, at +1 (888) 733-1521 for U.S. and Canada or +1 (310) 751-2636 for international. Modivcare is advised by Latham & Watkins LLP, Hunton Andrews Kurth LLP, Moelis & Company LLC, and FTI Consulting. The First Lien Agent, the First Lien Lenders and the Second Lien Noteholders executing the RSA are advised by Paul Hastings LLP and Lazard. Cautionary Note Regarding Forward-Looking Statements Statements contained in this release constitute 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are identified generally by the use of the terms 'intended', 'expected', 'estimates', 'will', and 'anticipates', and similar words or expressions indicating possible future expectations, events or actions. Forward-looking statements include statements regarding the Company's expectation about its ability to continue operating its business, fulfill its mission, make payments and meet obligations, and the Company's ability to implement the restructuring pursuant to the Chapter 11 cases, including the timetable of completing such transaction, if at all. Forward-looking statements are based on current expectations, assumptions, estimates and projections about the Company's business and its industry, and are not guarantees of future performance. These statements are subject to a number of known and unknown risks, uncertainties and other factors, many of which are beyond the Company's ability to control or predict, which may cause actual events to be materially different from those expressed or implied herein. The Company has provided additional information about the risks facing its business and the Company in its most recent annual report on Form 10-K, and in its subsequent periodic and current reports on Forms 10-Q and 8-K, filed by it with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statements were made and are expressly qualified in their entirety by the cautionary statements set forth herein and in the periodic and current reports filed with the Securities and Exchange Commission identified above, which you should read in their entirety before making an investment decision with respect to the Company's securities. The Company undertakes no obligation to update or revise any forward-looking statements contained in this report, whether as a result of new information, future events or otherwise, except as required by applicable law. About Modivcare Modivcare Inc. ("Modivcare" or the "Company") is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for public and private payors and their members. The Company's value-based solutions address the social determinants of health (SDoH) by connecting members to essential care services. By doing so, Modivcare helps health plans manage risks, reduce costs, and improve health outcomes. Modivcare is a provider of non-emergency medical transportation (NEMT), personal care services (PCS), and remote patient monitoring solutions (RPM). To learn more about Modivcare, please visit
